retatrutide phase 2 trial obesity nejm 2023 2023年度回顧】 Notable Articles of Day 3: Triple–Hormone-Receptor Agonist for — A Trial. N Engl J Med 2023; 389:514-526. 製圖：Sardinosis Retatrutide Research Guide: What the
Description
This is a common cause of hemorrhoids in pregnant women
Elderly patients may experience differential responses to GLP-1R agonists due to age-related changes in GLP1R expression, tumor microenvironment, and systemic physiology
That matters for surgery and procedures
However, integration of results from recent GLP-1 RA and older weight loss drug trials suggest a good correlation between weight loss and a decrease in BP (R 2 = 0.91 for SBP), a result mainly driven by GLP-1 RAs (Fig
They act on receptors in the brain to influence and decrease eating behavior
